A pooled analysis of serious infections and herpes zoster-related disease in Asian patients with rheumatoid arthritis treated with peficitinib (ASP015K) over a median of 3 years.
Yoshiya TanakaTsutomu TakeuchiDaisuke KatoYuichiro KanekoMusashi FukudaHiroyuki IzutsuMitsuhiro RokudaPublished in: Modern rheumatology (2022)
As expected in this peficitinib-treated population, older patients had increased risk of SI and HZD, and those receiving higher prednisolone doses had increased risk of SI.
Keyphrases